{"formats":[{"name":"JSON","format":"json","url":"\/downloads\/2025\/code-json\/54.1-3307.2.json"},{"name":"Plain Text","format":"text","url":"\/downloads\/2025\/code-text\/54.1-3307.2.txt"},{"name":"XML","format":"xml","url":"\/downloads\/2025\/code-xml\/54.1-3307.2.xml"},{"name":"HTML","format":"html","url":"\/downloads\/2025\/code-html\/54.1-3307.2.html"}],"law_id":70469,"edition_id":1,"section_id":70469,"structure_id":14478,"section_number":"54.1-3307.2","catch_line":"Approval of innovative programs","history":"2000, c. 876.","full_text":"A\n\nAny person who proposes to use a process or procedure related to the dispensing of drugs or devices or to the practice of pharmacy not specifically authorized by Chapter 33 (§ 54.1-3300 et seq.) of this title or by a regulation of the Board of Pharmacy may apply to the Board for approval to use such process or procedure. The application under this section may only include new processes or procedures, within the current scope of the practice of pharmacy, that relate to the form or format of prescriptions, the manner of transmitting prescriptions or prescription information, the manner of required recordkeeping, the use of unlicensed ancillary personnel in the dispensing process, and the use of new technologies in the dispensing process. The authority granted the Board under this section shall not authorize expansion of the current scope of practice for pharmacists and shall not interfere with the requirement that pharmacists only dispense drugs in accordance with instructions from a prescriber, as defined in § 54.1-3401.B\n\nThe application to the Board shall address safety to the public regarding the new process or procedure, any potential benefit to the public, promotion of scientific or technical advances in the practice of pharmacy, compliance with prescriber’s instructions for any drug dispensed, any impact the new process may have on the potential for diversion of drugs, maintenance in the integrity of and public confidence in the profession of pharmacy and of the drugs dispensed, impact on cost to the public and within the health care industry, means of monitoring the new process or procedure for any negative outcomes or other problems, and the reporting of such outcomes to the Board.C\n\nAn informal conference committee, composed of not less than two members of the Board and in accordance with \u00a7 2.2-4019, shall receive and review the application and any investigative report requested by the committee. The committee shall have the authority to grant or deny approval of the request. The committee may grant approval of the request unconditionally or may impose conditions on the approval as follows:1\n\nThe committee may grant approval for a finite period of time, after which time the applicant must provide additional information as requested by the committee in order to continue the approval;2\n\nThe committee may require that ongoing reports concerning performance and problems be submitted; or3\n\nThe committee may impose such other conditions as it deems necessary to provide assurance of public health and safety and accountability for controlled substances.D\n\nIf an applicant does not agree with the decision of the committee, the applicant may request a hearing before the Board or a panel of the Board, in accordance with § 2.2-4020.E\n\nApplication under this section shall be on a form provided by the Board and shall be accompanied by a fee determined by the Board.","order_by":null,"text":{"0":{"id":254306,"text":"Any person who proposes to use a process or procedure related to the dispensing of drugs or devices or to the practice of pharmacy not specifically authorized by Chapter 33 (§ 54.1-3300 et seq.) of this title or by a regulation of the Board of Pharmacy may apply to the Board for approval to use such process or procedure. The application under this section may only include new processes or procedures, within the current scope of the practice of pharmacy, that relate to the form or format of prescriptions, the manner of transmitting prescriptions or prescription information, the manner of required recordkeeping, the use of unlicensed ancillary personnel in the dispensing process, and the use of new technologies in the dispensing process. The authority granted the Board under this section shall not authorize expansion of the current scope of practice for pharmacists and shall not interfere with the requirement that pharmacists only dispense drugs in accordance with instructions from a prescriber, as defined in § 54.1-3401.","type":"section","prefixes":["A"],"prefix":"A","entire_prefix":"A","prefix_anchor":"A","level":1,"next_prefix":"B"},"1":{"id":254307,"text":"The application to the Board shall address safety to the public regarding the new process or procedure, any potential benefit to the public, promotion of scientific or technical advances in the practice of pharmacy, compliance with prescriber’s instructions for any drug dispensed, any impact the new process may have on the potential for diversion of drugs, maintenance in the integrity of and public confidence in the profession of pharmacy and of the drugs dispensed, impact on cost to the public and within the health care industry, means of monitoring the new process or procedure for any negative outcomes or other problems, and the reporting of such outcomes to the Board.","type":"section","prefixes":["B"],"prefix":"B","entire_prefix":"B","prefix_anchor":"B","level":1,"prior_prefix":"A","next_prefix":"C"},"2":{"id":254308,"text":"An informal conference committee, composed of not less than two members of the Board and in accordance with \u00a7 2.2-4019, shall receive and review the application and any investigative report requested by the committee. The committee shall have the authority to grant or deny approval of the request. The committee may grant approval of the request unconditionally or may impose conditions on the approval as follows:","type":"section","prefixes":["C"],"prefix":"C","entire_prefix":"C","prefix_anchor":"C","level":1,"prior_prefix":"B","next_prefix":"C1"},"3":{"id":254309,"text":"The committee may grant approval for a finite period of time, after which time the applicant must provide additional information as requested by the committee in order to continue the approval;","type":"section","prefixes":["C","1"],"prefix":"1","entire_prefix":"C1","prefix_anchor":"C1","level":2,"prior_prefix":"C","next_prefix":"C2"},"4":{"id":254310,"text":"The committee may require that ongoing reports concerning performance and problems be submitted; or","type":"section","prefixes":["C","2"],"prefix":"2","entire_prefix":"C2","prefix_anchor":"C2","level":2,"prior_prefix":"C1","next_prefix":"C3"},"5":{"id":254311,"text":"The committee may impose such other conditions as it deems necessary to provide assurance of public health and safety and accountability for controlled substances.","type":"section","prefixes":["C","3"],"prefix":"3","entire_prefix":"C3","prefix_anchor":"C3","level":2,"prior_prefix":"C2","next_prefix":"D"},"6":{"id":254312,"text":"If an applicant does not agree with the decision of the committee, the applicant may request a hearing before the Board or a panel of the Board, in accordance with § 2.2-4020.","type":"section","prefixes":["D"],"prefix":"D","entire_prefix":"D","prefix_anchor":"D","level":1,"prior_prefix":"C3","next_prefix":"E"},"7":{"id":254313,"text":"Application under this section shall be on a form provided by the Board and shall be accompanied by a fee determined by the Board.","type":"section","prefixes":["E"],"prefix":"E","entire_prefix":"E","prefix_anchor":"E","level":1,"prior_prefix":"D"}},"ancestry":[{"id":14478,"edition_id":1,"name":"Board of Pharmacy","identifier":"2","label":"article","depth":4,"order_by":1,"parent_id":13496,"metadata":{},"date_created":"2026-06-26 03:48:16","date_modified":"2026-06-26 03:48:16","permalink":{"id":243129,"object_type":"structure","relational_id":14478,"identifier":"2","token":"54.1\/III\/33\/2","url":"\/54.1\/III\/33\/2\/","edition_id":1,"permalink":0,"preferred":1}},{"id":13496,"edition_id":1,"name":"Pharmacy","identifier":"33","label":"chapter","depth":3,"order_by":1,"parent_id":12758,"metadata":{},"date_created":"2026-06-26 03:45:04","date_modified":"2026-06-26 03:45:04","permalink":{"id":243093,"object_type":"structure","relational_id":13496,"identifier":"33","token":"54.1\/III\/33","url":"\/54.1\/III\/33\/","edition_id":1,"permalink":0,"preferred":1}},{"id":12758,"edition_id":1,"name":"Professions and Occupations Regulated by Boards Within the Department of Health Professions","identifier":"III","label":"subtitle","depth":2,"order_by":1,"parent_id":12754,"metadata":{},"date_created":"2026-06-26 03:43:51","date_modified":"2026-06-26 03:43:51","permalink":{"id":241105,"object_type":"structure","relational_id":12758,"identifier":"III","token":"54.1\/III","url":"\/54.1\/III\/","edition_id":1,"permalink":0,"preferred":1}},{"id":12754,"edition_id":1,"name":"Professions and Occupations","identifier":"54.1","label":"title","depth":1,"order_by":1,"parent_id":null,"metadata":{},"date_created":"2026-06-26 03:43:51","date_modified":"2026-06-26 03:43:51","permalink":{"id":239313,"object_type":"structure","relational_id":12754,"identifier":"54.1","token":"54.1","url":"\/54.1\/","edition_id":1,"permalink":0,"preferred":1}}],"structure_contents":[{"id":74398,"structure_id":14478,"section_number":"54.1-3305","catch_line":"Board; membership; terms; meetings; quorum; officers","url":"\/54.1-3305\/","token":"54.1\/III\/33\/2\/54.1-3305","metadata":false},{"id":64309,"structure_id":14478,"section_number":"54.1-3306","catch_line":"Nominations","url":"\/54.1-3306\/","token":"54.1\/III\/33\/2\/54.1-3306","metadata":false},{"id":56891,"structure_id":14478,"section_number":"54.1-3307","catch_line":"Specific powers and duties of Board","url":"\/54.1-3307\/","token":"54.1\/III\/33\/2\/54.1-3307","metadata":false},{"id":55865,"structure_id":14478,"section_number":"54.1-3307.1","catch_line":"Repealed","url":"\/54.1-3307.1\/","token":"54.1\/III\/33\/2\/54.1-3307.1","metadata":false},{"id":70469,"structure_id":14478,"section_number":"54.1-3307.2","catch_line":"Approval of innovative programs","url":"\/54.1-3307.2\/","token":"54.1\/III\/33\/2\/54.1-3307.2","metadata":false},{"id":57744,"structure_id":14478,"section_number":"54.1-3307.3","catch_line":"Waiver of requirements; declared disaster or state of emergency","url":"\/54.1-3307.3\/","token":"54.1\/III\/33\/2\/54.1-3307.3","metadata":false},{"id":57403,"structure_id":14478,"section_number":"54.1-3308","catch_line":"Power of inspection","url":"\/54.1-3308\/","token":"54.1\/III\/33\/2\/54.1-3308","metadata":false},{"id":82048,"structure_id":14478,"section_number":"54.1-3309","catch_line":"Enforcement","url":"\/54.1-3309\/","token":"54.1\/III\/33\/2\/54.1-3309","metadata":false}],"previous_section":{"id":55865,"structure_id":14478,"section_number":"54.1-3307.1","catch_line":"Repealed","url":"\/54.1-3307.1\/","token":"54.1\/III\/33\/2\/54.1-3307.1","metadata":false},"next_section":{"id":57744,"structure_id":14478,"section_number":"54.1-3307.3","catch_line":"Waiver of requirements; declared disaster or state of emergency","url":"\/54.1-3307.3\/","token":"54.1\/III\/33\/2\/54.1-3307.3","metadata":false},"metadata":false,"official_url":"https:\/\/law.lis.virginia.gov\/vacode\/54.1-3307.2\/","history_text":"

This law was first created in 2000. The record of its establishment is cataloged in chapter 876<\/a> of that year\u2019s edition of \u201cActs of Assembly,\u201d the annual state publication listing all changes made to the Code of Virginia in that year.<\/p>","references":false,"refers_to":[{"id":85983,"section_number":"2.2-4019","catch_line":"Informal fact finding proceedings","order_by":null,"url":"\/2.2-4019\/"},{"id":72064,"section_number":"54.1-3300","catch_line":"Definitions","order_by":null,"url":"\/54.1-3300\/"}],"permalink":{"id":243147,"object_type":"law","relational_id":70469,"identifier":"54.1-3307.2","token":"54.1\/III\/33\/2\/54.1-3307.2","url":"\/54.1-3307.2\/","edition_id":1,"permalink":0,"preferred":1},"url":"\/54.1-3307.2\/","token":"54.1\/III\/33\/2\/54.1-3307.2","dublin_core":{"Title":"Approval of innovative programs","Type":"Text","Format":"text\/html","Identifier":"\u00a7 54.1-3307.2","Relation":"Code of Virginia"},"html":"\n\t\t\t\t\t\t

A.<\/span> Any person who proposes to use a process or procedure related to the dispensing of drugs or devices or to the practice of pharmacy<\/span> not specifically authorized by Chapter 33 (§ 54.1-3300<\/a> et seq.) of this title or by a regulation of the Board<\/span> of Pharmacy may apply to the Board<\/span> for approval to use such process or procedure. The application under this section may only include new processes or procedures, within the current scope of the practice of pharmacy<\/span>, that relate to the form or format of prescriptions, the manner of transmitting prescriptions or prescription information, the manner of required recordkeeping, the use of unlicensed ancillary personnel in the dispensing process, and the use of new technologies in the dispensing process. The authority granted the Board<\/span> under this section shall not authorize expansion of the current scope of practice for pharmacists<\/span> and shall not interfere with the requirement that pharmacists<\/span> only dispense<\/span> drugs in accordance with instructions from a prescriber, as defined in § 54.1-3401<\/a>. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

B.<\/span> The application to the Board<\/span> shall address safety to the public regarding the new process or procedure, any potential benefit to the public, promotion of scientific or technical advances in the practice of pharmacy<\/span>, compliance with prescriber’s instructions for any drug dispensed, any impact the new process may have on the potential for diversion<\/span> of drugs, maintenance in the integrity of and public confidence in the profession of pharmacy and of the drugs dispensed, impact on cost to the public and within the health care industry, means of monitoring the new process or procedure for any negative outcomes or other problems, and the reporting of such outcomes to the Board<\/span>. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

C.<\/span> An informal conference committee, composed of not less than two members of the Board<\/span> and in accordance with \u00a7 2.2-4019<\/a>, shall receive and review the application and any investigative report requested by the committee. The committee shall have the authority to grant or deny approval of the request. The committee may grant approval of the request unconditionally or may impose conditions on the approval as follows: <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

1.<\/span> The committee may grant approval for a finite period of time, after which time the applicant must provide additional information as requested by the committee in order<\/span> to continue the approval; <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

2.<\/span> The committee may require that ongoing reports concerning performance and problems be submitted; or <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

3.<\/span> The committee may impose such other conditions as it deems necessary to provide assurance of public health and safety and accountability for controlled substances. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

D.<\/span> If an applicant does not agree with the decision of the committee, the applicant may request a hearing<\/span> before the Board<\/span> or a panel<\/span> of the Board<\/span>, in accordance with § 2.2-4020<\/a>. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

E.<\/span> Application under this section shall be on a form provided by the Board<\/span> and shall be accompanied by a fee determined by the Board<\/span>. <\/i><\/a><\/p><\/section>","plain_text":" CODE OF VIRGINIA\n\nAPPROVAL OF INNOVATIVE PROGRAMS (\u00a7 54.1-3307.2)\n\nA. Any person who proposes to use a process or procedure related to the\ndispensing of drugs or devices or to the practice of pharmacy not specifically\nauthorized by Chapter 33 (§ 54.1-3300 et seq.) of this title or by a\nregulation of the Board of Pharmacy may apply to the Board for approval to use\nsuch process or procedure. The application under this section may only include\nnew processes or procedures, within the current scope of the practice of\npharmacy, that relate to the form or format of prescriptions, the manner of\ntransmitting prescriptions or prescription information, the manner of required\nrecordkeeping, the use of unlicensed ancillary personnel in the dispensing\nprocess, and the use of new technologies in the dispensing process. The\nauthority granted the Board under this section shall not authorize expansion of\nthe current scope of practice for pharmacists and shall not interfere with the\nrequirement that pharmacists only dispense drugs in accordance with instructions\nfrom a prescriber, as defined in § 54.1-3401.\n\nB. The application to the Board shall address safety to the public regarding the\nnew process or procedure, any potential benefit to the public, promotion of\nscientific or technical advances in the practice of pharmacy, compliance with\nprescriber’s instructions for any drug dispensed, any impact the new\nprocess may have on the potential for diversion of drugs, maintenance in the\nintegrity of and public confidence in the profession of pharmacy and of the\ndrugs dispensed, impact on cost to the public and within the health care\nindustry, means of monitoring the new process or procedure for any negative\noutcomes or other problems, and the reporting of such outcomes to the Board.\n\nC. An informal conference committee, composed of not less than two members of\nthe Board and in accordance with \u00a7 2.2-4019, shall receive and review the\napplication and any investigative report requested by the committee. The\ncommittee shall have the authority to grant or deny approval of the request. The\ncommittee may grant approval of the request unconditionally or may impose\nconditions on the approval as follows:\n\n 1. The committee may grant approval for a finite period of time, after which\n time the applicant must provide additional information as requested by the\n committee in order to continue the approval;\n\n 2. The committee may require that ongoing reports concerning performance and\n problems be submitted; or\n\n 3. The committee may impose such other conditions as it deems necessary to\n provide assurance of public health and safety and accountability for\n controlled substances.\n\nD. If an applicant does not agree with the decision of the committee, the\napplicant may request a hearing before the Board or a panel of the Board, in\naccordance with § 2.2-4020.\n\nE. Application under this section shall be on a form provided by the Board and\nshall be accompanied by a fee determined by the Board.\n\nHISTORY: 2000, c. 876.","edition":{"id":1,"name":"2025","slug":"2025","date_created":"2026-06-21 22:39:22","date_modified":"2026-06-21 22:39:22","current":1,"order_by":1,"last_import":null}}